Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2023-11-03 00:00:00 ET · period of report 2023-11-03 · accession 0001415889-23-014784 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-03 | 2023-11-03 | FENC | Raykov Rosty | CEO, Dir | M - OptEx | $1.59 | +74.8K | 307.6K | +32% | +$118.9K |
| D | 2023-11-03 | 2023-11-03 | FENC | Raykov Rosty | CEO, Dir | M - OptEx | $1.59 | -74.8K | 1.60M | -4% | -$118.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2023-11-03 | M | A | 74,793 | $1.59 | 307,631 | D | — | — | (F1) Shares acquired through the exercise of an option contract with a strike price of $1.59 and an expiration date of January 24, 2024. |
| 2 | Derivative | Option Contract | 2023-11-03 | M | D | 74,793 | $1.59 | 1,596,040 | D | $1.59 · 2014-01-24 to 2024-01-24 | 74,793 Options | (F2) Represents options granted on January 24, 2014, with a strike price of $1.59 and an expiration date of January 24, 2024. |